Literature DB >> 2878890

Antibodies to HTLV-I in Nigerian blood-donors, their relatives and patients with leukaemias, lymphomas and other diseases.

A F Fleming, R Maharajan, M Abraham, A G Kulkarni, S R Bhusnurmath, R A Okpara, E Williams, I Akinsete, J Schneider, H Bayer.   

Abstract

Antibodies to HTLV-I have been detected in sera from 15 (2.0%) of 736 adult blood-donors in Nigeria, in 4 (20.0%) of 20 patients with chronic lymphatic leukaemia, 3 (10.0%) of 30 with non-Hodgkin's lymphoma, one of 12 with Burkitt's lymphoma and one of 7 with acute lymphoblastic leukaemia. The frequency of positivity was higher (3.6%) in the blood-donors from the guinea and wooded savanna of northern Nigeria than in those from the rain-forest and mangrove swamps of southern Nigeria (1.8% in Lagos and 0.7% in Calabar). Two of the 3 seropositive patients with lymphoma had clinical presentation and courses similar to those of Japanese and Caribbean patients with adult T-cell leukaemia/lymphoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2878890     DOI: 10.1002/ijc.2910380605

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

Review 1.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

2.  Retroviruses.

Authors:  O H Jarrett
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

Review 3.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

4.  Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-kappa B2 p100 gene product: implications for viral latency.

Authors:  C Béraud; S C Sun; P Ganchi; D W Ballard; W C Greene
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

5.  A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution.

Authors:  K Kayembe; P Goubau; J Desmyter; R Vlietinck; H Carton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

6.  Human T-cell lymphotropic virus types I and II infections in patients with leukaemia/lymphoma and in subjects with sexually transmitted diseases in Nigeria.

Authors:  O D Olaleye; C C Ekweozor; Z L Li; I E Opala; Z Sheng; T N Onyemenem; S Rasheed
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy.

Authors:  A Gessain; A Louie; O Gout; R C Gallo; G Franchini
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

8.  Human T-cell lymphotropic virus in a population of pregnant women and commercial sex workers in South Western Nigeria.

Authors:  J C Forbi; A B Odetunde
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

9.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

10.  Frequency of adult T-cell leukaemia/lymphoma and HTLV-I in Ibadan, Nigeria.

Authors:  C K Williams; S S Alexander; A Bodner; A Levine; C Saxinger; R C Gallo; W A Blattner
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.